RECKLEEN Platform Revolutionizes Klebsiella Pneumoniae Gene Editing
Researchers have developed RECKLEEN, a breakthrough gene editing platform for Klebsiella pneumoniae that achieves up to 99.977% killing efficiency. The system addresses critical toxicity challenges that previously limited genetic manipulation of this dangerous pathogen.
